These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 26872621)

  • 21. [Diagnostic investigation of the detection of granulocyte-macrophage colony stimulating factor antibody in serum for pulmonary alveolar proteinosis].
    Li YQ; Chen YS; Li HR; Shang Y; Gao ZC
    Zhonghua Jie He He Hu Xi Za Zhi; 2013 May; 36(5):351-6. PubMed ID: 24047809
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antimelanoma differentiation-associated protein 5 antibody level is a novel tool for monitoring disease activity in rapidly progressive interstitial lung disease with dermatomyositis.
    Matsushita T; Mizumaki K; Kano M; Yagi N; Tennichi M; Takeuchi A; Okamoto Y; Hamaguchi Y; Murakami A; Hasegawa M; Kuwana M; Fujimoto M; Takehara K
    Br J Dermatol; 2017 Feb; 176(2):395-402. PubMed ID: 27452897
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Disseminated Cryptococcosis Due to Anti-Granulocyte-Macrophage Colony-Stimulating Factor Autoantibodies in the Absence of Pulmonary Alveolar Proteinosis.
    Kuo CY; Wang SY; Shih HP; Tu KH; Huang WC; Ding JY; Lin CH; Yeh CF; Ho MW; Chang SC; He CY; Chen HK; Ho CH; Lee CH; Chi CY; Ku CL
    J Clin Immunol; 2017 Feb; 37(2):143-152. PubMed ID: 28013480
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characteristics of a large cohort of patients with autoimmune pulmonary alveolar proteinosis in Japan.
    Inoue Y; Trapnell BC; Tazawa R; Arai T; Takada T; Hizawa N; Kasahara Y; Tatsumi K; Hojo M; Ichiwata T; Tanaka N; Yamaguchi E; Eda R; Oishi K; Tsuchihashi Y; Kaneko C; Nukiwa T; Sakatani M; Krischer JP; Nakata K;
    Am J Respir Crit Care Med; 2008 Apr; 177(7):752-62. PubMed ID: 18202348
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relationship between diffuse pulmonary fibrosis, alveolar proteinosis, and granulocyte-macrophage colony stimulating factor autoantibodies.
    Luisetti M; Bruno P; Kadija Z; Suzuki T; Raffa S; Torrisi MR; Campo I; Mariani F; Pozzi E; Trapnell BC; Mariotta S
    Respir Care; 2011 Oct; 56(10):1608-10. PubMed ID: 21513605
    [TBL] [Abstract][Full Text] [Related]  

  • 26. GM-CSF Autoantibody-positive Pulmonary Alveolar Proteinosis with Simultaneous Myeloproliferative Neoplasm.
    Imoto N; Harunori N; Furukawa K; Tange N; Murase A; Hayakawa M; Ichihara M; Iwata Y; Kosugi H
    Intern Med; 2017; 56(4):435-439. PubMed ID: 28202867
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pulmonary alveolar proteinosis: An autoimmune disease lacking an HLA association.
    Anderson K; Carey B; Martin A; Roark C; Chalk C; Nowell-Bostic M; Freed B; Aubrey M; Trapnell B; Fontenot A
    PLoS One; 2019; 14(3):e0213179. PubMed ID: 30845238
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of IL-15 in interstitial lung diseases in amyopathic dermatomyositis with anti-MDA-5 antibody.
    Takada T; Ohashi K; Hayashi M; Asakawa K; Sakagami T; Kikuchi T; Sato S
    Respir Med; 2018 Aug; 141():7-13. PubMed ID: 30053975
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Basiliximab may improve the survival rate of rapidly progressive interstitial pneumonia in patients with clinically amyopathic dermatomyositis with anti-MDA5 antibody.
    Zou J; Li T; Huang X; Chen S; Guo Q; Bao C
    Ann Rheum Dis; 2014 Aug; 73(8):1591-3. PubMed ID: 24739327
    [No Abstract]   [Full Text] [Related]  

  • 30. Granulocyte macrophage colony stimulating factor therapy for pulmonary alveolar proteinosis.
    Shende RP; Sampat BK; Prabhudesai P; Kulkarni S
    J Assoc Physicians India; 2013 Mar; 61(3):209-11. PubMed ID: 24475687
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Granulomatosis and polyangitis followed by alveolar proteinosis in a 32-year-old woman.
    Compa DR; Judson MA; Beegle SH
    Chest; 2012 May; 141(5):1359-1360. PubMed ID: 22553271
    [No Abstract]   [Full Text] [Related]  

  • 32. Anti-Ro 52 positive dermatomyositis presenting as rapidly progressive interstitial lung disease.
    Conway R; O'Donnell R; Fahy R; Doran MF; Cunnane G; O'Shea FD
    QJM; 2014 Jul; 107(7):593-4. PubMed ID: 24336848
    [No Abstract]   [Full Text] [Related]  

  • 33. An open-label trial of granulocyte macrophage colony stimulating factor therapy for moderate symptomatic pulmonary alveolar proteinosis.
    Venkateshiah SB; Yan TD; Bonfield TL; Thomassen MJ; Meziane M; Czich C; Kavuru MS
    Chest; 2006 Jul; 130(1):227-37. PubMed ID: 16840407
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Secondary pulmonary alveolar proteinosis in hematologic malignancies.
    Chaulagain CP; Pilichowska M; Brinckerhoff L; Tabba M; Erban JK
    Hematol Oncol Stem Cell Ther; 2014 Dec; 7(4):127-35. PubMed ID: 25300566
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative study of high-resolution CT findings between autoimmune and secondary pulmonary alveolar proteinosis.
    Ishii H; Trapnell BC; Tazawa R; Inoue Y; Akira M; Kogure Y; Tomii K; Takada T; Hojo M; Ichiwata T; Goto H; Nakata K;
    Chest; 2009 Nov; 136(5):1348-1355. PubMed ID: 19892674
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adenovirus-mediated granulocyte-macrophage colony-stimulating factor improves lung pathology of pulmonary alveolar proteinosis in granulocyte-macrophage colony-stimulating factor-deficient mice.
    Zsengellér ZK; Reed JA; Bachurski CJ; LeVine AM; Forry-Schaudies S; Hirsch R; Whitsett JA
    Hum Gene Ther; 1998 Sep; 9(14):2101-9. PubMed ID: 9759936
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rare lung disease II: pulmonary alveolar proteinosis.
    Juvet SC; Hwang D; Waddell TK; Downey GP
    Can Respir J; 2008; 15(4):203-10. PubMed ID: 18551202
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pulmonary alveolar proteinosis during a 30-year observation. Diagnosis and treatment.
    Fijołek J; Wiatr E; Radzikowska E; Bestry I; Langfort R; Polubiec-Kownacka M; Prokopowicz J; Roszkowski-Śliż K
    Pneumonol Alergol Pol; 2014; 82(3):206-17. PubMed ID: 24793148
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Detection of granulocyte-macrophage colony-stimulating factor in patients with pulmonary alveolar proteinosis.
    Carraway MS; Ghio AJ; Carter JD; Piantadosi CA
    Am J Respir Crit Care Med; 2000 Apr; 161(4 Pt 1):1294-9. PubMed ID: 10764326
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aerosol granulocyte-macrophage colony-stimulating factor for pulmonary alveolar proteinosis.
    Wylam ME; Ten R; Prakash UB; Nadrous HF; Clawson ML; Anderson PM
    Eur Respir J; 2006 Mar; 27(3):585-93. PubMed ID: 16507860
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.